Skip to main content

Table 1 Summary of clinicopathological characteristics of 29 UGCs

From: Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data

Case no

Age/sex

Size of mucosal lesion (cm)

Macroscopic type*

Histological type*

Sampling region for aCGH

Depth of invasion†

LN meta†

Stage†

Intramucosal part

Invasive part

LS

not LS

TC

M101

79/F

8.5 × 4.0

0(IIc)

SIG > TC

+

NT

NT

 

T1 (m)

N0

IA

M102

48/F

9.5 × 5.0

0(IIc)

SIG > POR1

+

NT

-

 

T1 (m)

N0

IA

M103

57/M

1.4 × 0.8

0(IIc)

SIG

+

NT

-

 

T1 (m)

N0

IA

M104

76/F

6.0 × 5.0

0(IIc)

SIG

+

NT

-

 

T1 (m)

N0

IA

M105

50/M

1.5 × 1.2

0(IIc)

SIG

+

NT

-

 

T1 (m)

N0

IA

M106

60/F

1.2 × 1.0

0(IIc)

SIG

+

-

-

 

T1 (m)

N0

IA

M107

49/F

4.0 × 2.5

0(IIc + III)

SIG > POR1

+

NT

-

 

T1 (m)

N0

IA

M108

48/F

6.0 × 2.8

0(IIc)

SIG > POR1 > TC

+

POR

NT

 

T1 (m)

N0

IA

M109

51/M

5.3 × 3.3

0(IIc + III)

SIG

+

SIG

-

 

T1 (m)

N0

IA

SM101

71/F

0.9 × 0.8

0(IIc)

SIG > POR2

+

NT

-

NT

T1 (sm2)

N2

II

A102

72/F

5.0 × 3.0

0(IIc + IIb)

POR2 > POR1 > SIG

+

SIG

-

POR2

T2 (mp)

N1

II

A103

79/F

12.0 × 8.5

0(IIa + IIb)

POR1 > TC > SIG > POR2

+

POR

NI

NT

T2 (mp)

N1

II

A104

49/M

2.8 × 2.5

0(IIc + III)

SIG > POR2 > TC

+

NT

NT

POR2

T2 (ss)

N1

II

SM105

59/F

11.5 × 7.0

0(IIa + IIc)

SIG > TC > POR2

+

TUB2

NT

POR2

T1 (sm)

N1

IB

SM106

72/M

3.7 × 2.3

0(IIc)

SIG > POR1

+

POR

-

NT

T1 (sm2)

N0

IA

A107

48/F

12.0 × 6.5

0(IIc + III)

SIG > POR2 > POR1 > MUC

+

POR

-

POR2

T3 (se)

N2

IIIB

A108

46/M

4.0 × 2.8

0(IIc + III)

POR2 > POR1 > SIG

NI

NI

-

POR2

T2 (mp)

N2

IIIA

A109

55/M

3.8 × 3.3

0(IIc + III)

SIG > POR1

+

POR

-

SIG

T1 (sm2)

N0

IA

A110

57/M

5.5 × 2.2

0(IIc)

POR2 > SIG > TC

+

POR

-

POR2

T2 (mp)

N1

II

A111

54/F

8.0 × 7.0

3

POR2 > SIG

+

POR

-

POR2

T3 (se)

N2

IIIB

SM201

75/F

3.7 × 3.0

2

POR1 > TC

-

POR/TUB2

+

POR

T1 (sm2)

N0

IA

A202

60/M

4.0 × 3.8

0(IIc)

POR2 > POR1 > TC > SIG

-

POR/TUB2

+

POR

T2 (mp)

N0

IB

SM203

71/M

4.5 × 2.0

0(IIa + IIc)

POR1 > TC > SIG

-

POR/TUB2

+

POR

T1 (sm2)

N0

IA

A204

65/F

5.5 × 3.0

3

POR2 > TC > POR1

-

POR/TUB2

+

POR

T3 (se)

N3

IV

A205

54/M

7.4 × 5.8

5

POR2 > TC > POR1

-

POR/TUB2

+

POR

T3 (se)

N0

II

A206

67/F

5.5 × 4.0

4

POR2 > TC > POR1

-

POR/TUB2

+

NT

T4 (si)

N2

IV

A207

52/M

6.0 × 4.0

4

POR1 > POR2 > SIG > TC

-

POR/TUB2

+

POR

T3 (se)

N3

IV

A208

75/M

9.0 × 7.0

2

POR1 > TC

-

POR/TUB2

+

POR

T2 (mp)

N1

II

A209

50/F

2.3 × 0.8

3

POR2 > SIG > POR1 > TC

-

POR/TUB2

+

POR

T2 (mp)

N2

IIIA

  1. *Japanese classification of gastric carcinoma, modified.
  2. †TNM classification.
  3. UGCs, Undifferentiated gastric carcinomas; aCGH, Array CGH; LN, Lymph node, LS, Layered structure; TC, Tubular component; SIG, Signet ring cell carcinoma; POR, Poorly differentiated adenocarcinoma; POR1, Solid POR; POR2, Non-solid POR; TUB2, Moderately differentiated adenocarcinoma; MUC, Mucinous adenocarcinoma; m, mucosa; sm, submucosa; mp, muscular propria; ss, subserora; se, serosal exposure; si, invasion to adjacent structures; M, Male; F, Female; NT, Not tested; NI, Not informative.